MD Anderson Cancer Center researchers are relying on a powerful supercomputer to develop a dosing protocol for an MRI-guided radiation therapy for cancer care, called MRI-linac. The Lonestar system at the Texas Advanced Computing Center (TACC) is helping researchers fine-tune the radiation dosing mechanism so that just the right amount of radiation is delivered to the Read more…
Using the advanced computational resources at the Texas Advanced Computing Center (TACC) at The University of Texas at Austin, researchers uncovered a link between Alzheimer’s disease and cancer that may pave the way for better treatment options and new medicines. The two afflictions share a pathway in gene transcription, a process essential for cell reproduction Read more…
AI prodigy and former Jeopardy champion Watson is ready for a career in medicine.
NYU researchers use TACC and XSEDE supercomputers to model the effect of carcinogenic compounds on DNA.
IBM and Sloan-Kettering turn technology into cancer fighter.
As part of its Powering the Possible charitable program, Dell is providing the secure cloud-based IT infrastructure to support the world’s first personalized medicine clinical trial for pediatric cancer. The research is being conducted by the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) at the Van Andel Research Institute (VARI) and supported by The Translational Genomics Research Institute (Tgen).
The MD Anderson Cancer Research Center at the University of Texas is gearing up to become the home of the world’s largest private cloud dedicated to understanding genome-cancer links.
The need to analyze increasingly large amounts of genomics and proteomics data has meant that research institutions such as the Spanish National Cancer Research Centre (CNIO) allocate an increasing amount of to time and budget provisioning, as well as managing and maintaining their scientific computing infrastructure, areas that not their core business. A European IT company, powered by AWS is showing how cloud computing can mitigate these problems and get researchers back to their mission.